On October 5, 2018, the U.S. International Trade Commission (“Commission”) issued a press release announcing their vote to institute an investigation of Certain Obstructive Sleep Apnea Treatment Mask Systems and Components Thereof (Inv. No. 337-TA-1136).

By way of background, this investigation is based on a September 10, 2018 complaint filed by Fisher & Paykel Healthcare Ltd. of New Zealand alleging violation of Section 337 by way of unlawful importation into the U.S., selling for importation, and/or selling within the U.S. after importation certain obstructive sleep apnea treatment mask systems and components thereof that infringe one or more claims of U.S. Patent Nos. 9,333,315; 9,517,317; 9,539,405; 9,907,925; and 9,974,914. See our September 10, 2018 post for more details on the complaint.

Read More

On October 2, 2018, Chief ALJ Charles E. Bullock issued Order No. 24 in Certain Carburetors and Products Containing Such Carburetors (Inv. No. 337-TA-1123).

By way of background, this investigation is based on a June 12, 2018 complaint filed by Walbro, LLC (“Walbro” or “Complainant”) of Tucson Arizona alleging violation of Section 337 by way of unlawful importation into the U.S., selling for importation, and/or selling within the U.S. after importation of certain carburetors and products containing same that infringe one or more claims of U.S. Patent Nos. 6,394,424; 6,439,547; 6,533,254; 6,540,212; and 7,070,173. See our June 12, 2018 post for more details on the complaint.

Read More

On October 4, 2018, Chief ALJ Charles E. Bullock issued the public version of Order No. 55 (dated August 31, 2018) in Certain Integrated Circuits with Voltage Regulators and Products Containing Same (Inv. No. 337-TA-1024).

By way of background, this investigation is based on a September 12, 2016 complaint filed by R2 Semiconductor, Inc. alleging violation of Section 337 by way of unlawful importation into the U.S., selling for importation, and/or selling within the U.S. after importation certain integrated circuits with voltage regulators and products containing same that infringe one or more claims of U.S. Patent No. 8,233,250. See our October 13, 2016 post for more details on the Notice of Investigation.

Read More

On October 3, 2018, Juul Labs, Inc. of San Francisco, California (“JLI”) filed a complaint (part 1 and part 2) requesting that the ITC commence an investigation pursuant to Section 337.

The complaint alleges that the following entities (collectively, the “Proposed Respondents”) unlawfully import into the U.S., sell for importation, and/or sell within the U.S. after importation certain electronic nicotine delivery systems and components thereof that infringe one or more claims of U.S. Patent Nos. 10,070,669 (the ’669 patent), 10,076,139 (the ’139 patent), 10,045,568 (the ’568 patent), and 10,058,130 (the ’130 patent) (collectively, the “asserted patents”):

Read More

On October 1, 2018, the U.S. International Trade Commission (“Commission”) issued a press release announcing their vote to institute an investigation of Certain Sleep-Disordered Breathing Treatment Mask Systems and Components Thereof (Inv. No. 337-TA-1134).

By way of background, this investigation is based on an August 31, 2018 complaint filed by ResMed Corp. and ResMed Inc. of San Diego, California, and ResMed Ltd. of Australia alleging violation of Section 337 by way of unlawful importation into the U.S., selling for importation, and/or selling within the U.S. after importation certain sleep-disordered breathing treatment mask systems and components thereof that infringe one or more claims of U.S. Patent Nos. 9,119,931 (“the ’931 patent”), 9,027,556 (“the ’556 patent”), 9,962,511 (“the ’511 patent”), 9,962,510 (“the ’510 patent”), and 9,937,315 (“the ’315 patent”). See our August 31, 2018 post for more details on the complaint.

Read More